IT8748116A0 - Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche - Google Patents

Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche

Info

Publication number
IT8748116A0
IT8748116A0 IT8748116A IT4811687A IT8748116A0 IT 8748116 A0 IT8748116 A0 IT 8748116A0 IT 8748116 A IT8748116 A IT 8748116A IT 4811687 A IT4811687 A IT 4811687A IT 8748116 A0 IT8748116 A0 IT 8748116A0
Authority
IT
Italy
Prior art keywords
preventive
therapeutic agents
diabetic complications
glycine derivatives
glycine
Prior art date
Application number
IT8748116A
Other languages
English (en)
Other versions
IT1206822B (it
Inventor
Murase Masao
Maruo Shigeaki
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of IT8748116A0 publication Critical patent/IT8748116A0/it
Application granted granted Critical
Publication of IT1206822B publication Critical patent/IT1206822B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT8748116A 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche IT1206822B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15214986 1986-06-27

Publications (2)

Publication Number Publication Date
IT8748116A0 true IT8748116A0 (it) 1987-06-26
IT1206822B IT1206822B (it) 1989-05-03

Family

ID=15534103

Family Applications (2)

Application Number Title Priority Date Filing Date
IT8748116A IT1206822B (it) 1986-06-27 1987-06-26 Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Family Applications After (1)

Application Number Title Priority Date Filing Date
IT8748117A IT1206823B (it) 1986-06-27 1987-06-26 Derivati di glicina quali agenti preventivi e terapeutici per le complicanze diabetiche

Country Status (6)

Country Link
US (2) US4785018A (it)
JP (2) JPS63119455A (it)
DE (2) DE3721222A1 (it)
FR (2) FR2600647B1 (it)
GB (2) GB2192002B (it)
IT (2) IT1206822B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196849B (it) * 1986-12-16 1988-11-25 Rotta Research Lab Nuovi derivati degli acidi 5 pentilammino 5 oxo pentaoico e 4 pentilammino 4 oxo butanoico ad attivita antagonista della colecistochinina e procedimento per la loro preparazione
CA1307537C (en) * 1987-12-23 1992-09-15 Jay E. Wrobel N-naphthoylglycines as aldose reductase inhibitors
US4962224A (en) * 1987-12-23 1990-10-09 American Home Products Corporation N-naphthoylglycines as aldose reductase inhibitors
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
CN1207730A (zh) * 1995-11-24 1999-02-10 史密丝克莱恩比彻姆股份公司 喹啉衍生物
EP1491533A3 (en) * 1997-03-14 2005-01-19 Cephalon, Inc. Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors
WO2002098421A1 (en) * 2001-06-05 2002-12-12 University Of Maryland, Baltimore Novel treatment for neurological and psychiatric disorders
WO2006034491A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928610A (en) * 1970-06-06 1975-12-23 Hoechst Ag Benzene sulfonyl-urea preparation for treatment of diabetes mellitus and a method for treatment
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels
JPS5216367A (en) * 1975-07-21 1977-02-07 Rikagaku Kenkyusho Plant growth control agent
US4195984A (en) * 1979-03-12 1980-04-01 Abbott Laboratories Herbicides derived from dihalo isonicotinoyl derivatives of amino acids
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
CA1182472A (en) * 1981-03-02 1985-02-12 Kazimir Sestanj N-[(2-naphthalenyl)thioxomethyl]glycine derivatives
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
US4604406A (en) * 1984-11-16 1986-08-05 Ayerst, Mckenna & Harrison, Inc. N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs

Also Published As

Publication number Publication date
GB2192002B (en) 1990-04-11
IT1206823B (it) 1989-05-03
DE3721223C2 (it) 1991-11-14
US4785018A (en) 1988-11-15
US4970214A (en) 1990-11-13
GB2192002A (en) 1987-12-31
FR2600647B1 (fr) 1991-10-18
GB8715055D0 (en) 1987-08-05
GB2193210B (en) 1990-03-28
FR2600647A1 (fr) 1987-12-31
IT8748117A0 (it) 1987-06-26
JPS6399057A (ja) 1988-04-30
JPS63119455A (ja) 1988-05-24
DE3721222A1 (de) 1988-01-14
FR2600646B1 (fr) 1990-01-26
IT1206822B (it) 1989-05-03
FR2600646A1 (fr) 1987-12-31
DE3721223A1 (de) 1988-01-14
GB8715056D0 (en) 1987-08-05
GB2193210A (en) 1988-02-03

Similar Documents

Publication Publication Date Title
DE3781263D1 (de) Peptid-derivate und deren verwendung in der therapie.
GR3002659T3 (en) Pharmaceutical composition for treating inflammation in the eye
TR23322A (tr) Alfa-aril-alfa-feniletil-1h-1,2,4-triazol-1-propannitriller
DK90089D0 (da) Hudbehandlingspraeparat
DK295190A (da) Kosmetik- og hudbehandlingssammensaetninger
PT87554A (pt) Didinfecting and sterilizing composition
IT8748116A0 (it) Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
EP0437026A3 (en) Use of tandospirone in the treatment of depression
DE3876075T2 (de) Uv-haertbare und in schattengebieten mit feuchtigkeit haertbare zusammensetzungen.
GB2201171B (en) Compositions for use in the treatment of cellulosic materials and their preparation
AU3752189A (en) Pharmaceutical compositions and use thereof in treating inflammation
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
GB2222022B (en) Improvements in and relating to semiconductor lasers
HK105091A (en) Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
IT1187768B (it) Dispositivo per l'ammortizzazione delle barelle delle autolettighe in genere
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes
BR8902395A (pt) Composicao curavel e artigo
ATE79636T1 (de) Peptid-derivate und deren verwendung in der therapie.
NO933877D0 (no) Fremgangsmaate for aa forhindre blokkering i katetere
HK1394A (en) Pharmaceutical composition for treating inflammation in the eye
LV5819A4 (lv) (-)-benzhidrilsulfinilacetamids ta iegusanas panemiens un ta izmantosana terapija
RO105585B1 (ro) Compozitie medicamentoasa folosita in tratamentul ulcerului de gamba
IT8819742A0 (it) Procedimento per il riempimento e/o l'otturazione in interventi chirurgici e odontoiatrici.
LT2576B (lt) Cholesterino nustatymo kraujyje budas
TH6324EX (th) อุปกรณ์สำหรับใช้ในการรักษาโรคเหงือก

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19930419